Brodalumab in the Treatment of Various Forms of Psoriasis: A Narrative Review
Background: Brodalumab is a fully human monoclonal antibody that selectively targets the interleukin-17 receptor A (IL-17RA), blocking the activity of pro-inflammatory IL-17 cytokines. Purpose: The purpose of this study was to describe the efficacy and safety of brodalumab in treating various forms...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| シリーズ: | Journal of Dermatology and Dermatologic Surgery |
| 主題: | |
| オンライン・アクセス: | https://journals.lww.com/10.4103/jdds.jdds_41_24 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
